Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

687 studies match

clinicaltrialsPublishedShowing 101–150 of 687 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03604198	Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome	active not recruiting	Phase 2	125	Corcept TherapeuticsINDUSTRY	9	Aug 25, 2026	clinicaltrials
NCT04165070	KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)	recruiting	Phase 1 / Phase 2	450	Merck Sharp & Dohme LLCINDUSTRY